Genetic variation in SLC7A2 interacts with calcium and magnesium intakes in modulating the risk of colorectal polyps
- PMID: 28501704
- PMCID: PMC5583031
- DOI: 10.1016/j.jnutbio.2017.04.016
Genetic variation in SLC7A2 interacts with calcium and magnesium intakes in modulating the risk of colorectal polyps
Abstract
Solute carrier family 7, member 2 (SLC7A2) gene encodes a protein called cationic amino acid transporter 2, which mediates the transport of arginine, lysine and ornithine. l-Arginine is necessary for cancer development and progression, including an important role in colorectal cancer pathogenesis. Furthermore, previous studies found that both calcium and magnesium inhibit the transport of arginine. Thus, calcium, magnesium or calcium:magnesium intake ratio may interact with polymorphisms in the SLC7A2 gene in association with colorectal cancer. We conducted a two-phase case-control study within the Tennessee Colorectal Polyps Study. In the first phase, 23 tagging single-nucleotide polymorphisms in the SLC7A2 gene were included for 725 colorectal adenoma cases and 755 controls. In the second phase conducted in an independent set of 607 cases and 2113 controls, we replicated the significant findings in the first phase. We observed that rs2720574 significantly interacted with calcium:magnesium intake ratio in association with odds of adenoma, particularly multiple/advanced adenoma. In the combined analysis, among those with a calcium:magnesium intake ratio below 2.78, individuals who carried GC/CC genotypes demonstrated higher odds of adenoma [OR (95% CI):1.36 (1.11-1.68)] and multiple/advanced adenoma [OR (95% CI): 1.68 (1.28, 2.20)] than those who carried the GG genotype. The P values for interactions between calcium:magnesium intake ratio and rs2720574 were .002 for all adenomas and <.001 for multiple/advanced adenoma. Among those with the GG genotype, a high calcium:magnesium ratio was associated with increased odds of colorectal adenoma [OR (95% CI): 1.73 (1.27-2.36)] and advanced/multiple adenomas [1.62 (1.05-2.50)], whereas among those with the GC/CC genotypes, high calcium:magnesium ratio was related to reduced odds of colorectal adenoma [0.64 (0.42-0.99)] and advanced/multiple adenomas [0.55 (0.31-1.00)].
Keywords: Calcium; Colorectal polyps; Gene–nutrient interaction; Magnesium; SLC7A2.
Copyright © 2017 Elsevier Inc. All rights reserved.
Conflict of interest statement
No author has a potential conflict to disclose.
Similar articles
-
The relation of magnesium and calcium intakes and a genetic polymorphism in the magnesium transporter to colorectal neoplasia risk.Am J Clin Nutr. 2007 Sep;86(3):743-51. doi: 10.1093/ajcn/86.3.743. Am J Clin Nutr. 2007. PMID: 17823441 Free PMC article.
-
Calcium/magnesium intake ratio, but not magnesium intake, interacts with genetic polymorphism in relation to colorectal neoplasia in a two-phase study.Mol Carcinog. 2016 Oct;55(10):1449-57. doi: 10.1002/mc.22387. Epub 2015 Aug 31. Mol Carcinog. 2016. PMID: 26333203 Free PMC article.
-
Mediterranean dietary components are inversely associated with advanced colorectal polyps: A case-control study.World J Gastroenterol. 2018 Jun 28;24(24):2617-2627. doi: 10.3748/wjg.v24.i24.2617. World J Gastroenterol. 2018. PMID: 29962818 Free PMC article.
-
Increased Risk of Colorectal Cancer Tied to Advanced Colorectal Polyps: An Untapped Opportunity to Screen First-Degree Relatives and Decrease Cancer Burden.Am J Gastroenterol. 2020 Jul;115(7):980-988. doi: 10.14309/ajg.0000000000000639. Am J Gastroenterol. 2020. PMID: 32618646 Free PMC article. Review.
-
Role of the serrated pathway in colorectal cancer pathogenesis.Gastroenterology. 2010 Jun;138(6):2088-100. doi: 10.1053/j.gastro.2009.12.066. Gastroenterology. 2010. PMID: 20420948 Review.
Cited by
-
Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.Mol Metab. 2024 Jun;84:101952. doi: 10.1016/j.molmet.2024.101952. Epub 2024 May 3. Mol Metab. 2024. PMID: 38705513 Free PMC article. Review.
-
Loss of solute carrier family 7 member 2 exacerbates inflammation-associated colon tumorigenesis.Oncogene. 2019 Feb;38(7):1067-1079. doi: 10.1038/s41388-018-0492-9. Epub 2018 Sep 10. Oncogene. 2019. PMID: 30202097 Free PMC article.
-
An integrated approach to understand fluid shear stress-driven and reactive oxygen species-mediated metastasis of colon adenocarcinoma through mRNA-miRNA-lncRNA-circRNA networks.Mol Genet Genomics. 2022 Sep;297(5):1353-1370. doi: 10.1007/s00438-022-01924-z. Epub 2022 Jul 13. Mol Genet Genomics. 2022. PMID: 35831469
-
Comprehensive Analysis on Prognostic Signature Based on T Cell-Mediated Tumor Killing Related Genes in Gastric Cancer.Biochem Genet. 2024 Feb;62(1):504-529. doi: 10.1007/s10528-023-10436-3. Epub 2023 Jun 29. Biochem Genet. 2024. PMID: 37386336
-
Magnesium in Aging, Health and Diseases.Nutrients. 2021 Jan 30;13(2):463. doi: 10.3390/nu13020463. Nutrients. 2021. PMID: 33573164 Free PMC article. Review.
References
-
- Chubak J, et al. Aspirin Use for the Prevention of Colorectal Cancer: An Updated Systematic Evidence Review for the US Preventive Services Task Force. Agency for Healthcare Research and Quality (US); Rockville (MD): 2015. U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. - PubMed
-
- Grabon W, et al. L-arginine as a factor increasing arginase significance in diagnosis of primary and metastatic colorectal cancer. Clin Biochem. 2009;42(4–5):353–7. - PubMed
-
- Yoon CY, et al. Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase. Int J Cancer. 2007;120(4):897–905. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous